Skip to main content
. Author manuscript; available in PMC: 2016 May 30.
Published in final edited form as: Nat Biotechnol. 2015 Nov 30;34(1):47–54. doi: 10.1038/nbt.3367

Figure 2. Overview of the IP map.

Figure 2

(a) Clustered heatmap of the drugs and immune cell state changes organized by the immunemod score. Venn diagrams reflect the number of drugs that shift immune cell states a specific or non-specific direction. (b) Two-dimensional heatmap of the stable cell and drug clusters with a significant enrichment for at least one cell type (rows) or a level 1 therapeutic class (columns). Therepeutic classes include: H = Systemic hormonal preparations, excl. sex hormones and insulins, V = Various, B = Blood and blood forming organs, P = Anti-parasitic products, M = Musculo-skeletal system, L = Anti-neoplastic and immunomodulating agents, G = Genito urinary system and sex hormones, R = Respiratory system, A = Alimentary tract and metabolism, D = Dermatologicals, J = Anti-infectives for systemic use, S = Sensory organs, N = Nervous system, and C = Cardiovascular system. Areas of corresponding circles represent the number of cells or drug per cluster (2–14 cells, 2–13 drugs). Gray colored squares indicate predicted interaction between at least one cell-drug pair in the pairs of clusters.

HHS Vulnerability Disclosure